Financial: Becky Khayum is owner of MemoryCare Corporation and a consultant on Communication Bridge research study at the Cognitive Neurology and Alzheimer’s Disease Center at the Northwestern Feinberg School of Medicine.
Emily Rogalski is a salaried Associate Professor with Northwestern University Feinberg School of Medicine and receives grants from NIH, foundations, and other philanthropic sources.
Becky Khayum and Emily Rogalski receive compensation from MedBridge for this course. There is no financial interest beyond the production of this course.
Non-financial: Becky Khayum and Emily Rogalski have no competing non-financial interests or relationships with regard to the content presented in this course.
Satisfactory completion requirements: All disciplines must complete learning assessments to be awarded credit, no minimum score required unless otherwise specified within the course.
Becky Khayum, MS, CCC-SLP
Becky Khayum is a speech-language pathologist and co-founder of MemoryCare Corporation, a company that provides therapy, support, and counseling for individuals with neurodegenerative disease in the Chicago and Indianapolis areas. She specializes in the non-pharmacological treatment of dementia syndromes, with a focus on person-centered care. Khayum also participates in research targeting treatment approaches for Primary…Read full bio
Emily Rogalski, PhD
Dr. Emily Rogalski is a neuroscientist and Associate Professor of Psychiatry and Behavioral Sciences at Northwestern University’s Feinberg School of Medicine. She currently serves as Associate Director of the Mesulam Cognitive Neurology and Alzheimer's Disease Center and as Imaging Core Leader of our NIA-funded Alzheimer’s Disease Center. Dr. Rogalski research falls under the broad umbrella…Read full bio
1. What is the Difference Between Alzheimer’s and Dementia?
This chapter will describe different neurodegenerative dementia syndromes and their relationship to brain anatomy and underlying neuropathology, including some of the challenges in reaching the correct diagnosis. It will also describe the key members of the care team and their roles in diagnosis and treatment.
2. Person-Centered Cognitive-Communication Assessment
The heterogeneity of symptoms and the progressive nature of the neurodegenerative dementia syndromes requires a holistic approach, with the following variables taken into account when an SLP is designing a plan of treatment: (1) individual’s cognitive/communication strengths and weaknesses and their severity, (2) individual’s hobbies and interests, (3) individual’s (and care partners) assessment of challenges and therapy goals, (4) motivation, and (5) care partner involvement/support. Discussion will cover how to integrate the use of functionally-focused standardized tests into a person-centered, dynamic assessment that will identify ways to increase life participation in meaningful activities. The A-FROM / life participation approach for aphasia (LPAA) and Michelle Bourgeois’ “Flip the Rehab Model” will be introduced as important models to guide person-centered assessment and treatment planning.
3. Functional, Reimbursable Goal-Setting Across Clinical Settings
This chapter will describe the various care settings where SLPs may provide treatment for individuals with different dementia syndromes and considerations for goal development. Treatment settings include outpatient clinics, independent/assisted living communities, home health, hospital (inpatient), subacute care (skilled nursing facility), and memory units. Practical strategies for utilizing an interdisciplinary team approach to care, increasing involvement of family members, and getting staff buy-in will be discussed. Goal writing and how to document progress for a neurodegenerative condition will also be discussed, to ensure reimbursement.